GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

Rating:
Buy REGN
up 2,326.70 %

Regeneron Pharmaceuticals, Inc. (REGN) rated Buy

Posted on: Monday,  Dec 3, 2007  9:25 AM ET by Caris & Company

Caris & Company rated Buy Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 12/03/2007, when the stock price was $22.17.
Since then, Regeneron Pharmaceuticals, Inc. has gained 2326.70% as of 01/27/2016's recent price of $538.00.
If you would have followed this Caris & Company's recommendation on REGN, you would have gained 2326.7% of your investment in 2977 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/3/2007 9:25 AM Buy
None
22.17 23.00
as of 8/27/2015
1 Week down  -7.08 %
1 Month up  3.25 %
3 Months up  9.47 %
1 YTD up  95.46 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy